Viewing Study NCT06474468

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:33 PM
Ignite Modification Date: 2026-04-23 @ 6:17 AM
Study NCT ID: NCT06474468
Status: RECRUITING
Last Update Posted: 2025-01-03
First Post: 2024-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced or Metastatic Esophageal Cancer View
Keywords: